Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MDXG

3 Growth Stocks Under $10 You Should Own

With a stable global economic growth outlook and easing U.S. inflation, investing in growth stocks like Viavi Solutions (VIAV), Coursera (COUR), and MiMedx Group (MDXG) could be wise. These stocks boast solid fundamentals and significant growth potential for investors seeking opportunities under $10. Read on.

3 A-Rated Medical Stocks to Watch and Buy

3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality healthcare. Therefore, it could be wise to buy fundamentally strong medical stocks GSK (GSK), National HealthCare (NHC), and MiMedx Group…

3 Medical Stocks Set to Soar in 2024

3 Medical Stocks Set to Soar in 2024

The healthcare industry in 2024 is shaped by personalized medicine and innovative technologies in pharmacy, diagnostic testing, and medical devices. Hence, fundamentally strong medical stocks CVS Health (CVS), Agilent Technologies (A), and MiMedx Group (MDXG) could garner significant gains in the upcoming year. Read more….

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Solid Medical Stocks to Watch for Year-End Success and Beyond

The medical sector is poised for significant growth, driven by technological advances, robust demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality healthcare. To that end, it could be wise to buy fundamentally strong medical stocks Elevance Health (ELV), MiMedx Group (MDXG),…

3 Medical Stocks Diagnosing Weekly Profit Potential

The healthcare industry is experiencing rapid transformation and is well-positioned to thrive due to the rising demand for high-quality healthcare and medical device innovation. Hence, fundamentally strong medical stocks Cardinal Health (CAH), MiMedx Group (MDXG), and Nature's Sunshine Products (NATR), with robust profit potential, might be solid investments now. Read…

3 Medical Stocks Elevating Investors' Profit Potential

Within the rapidly evolving healthcare landscape, opportunities arise from operational improvements, making the sector poised for significant expansion. Hence, fundamentally strong medical stocks Cardinal Health (CAH), Fresenius SE (FSNUY), and MiMedx Group (MDXG), with robust profit potential, might be solid investments. Read more….

Are These 3 Medical Stocks a Safe Investment?

The future of the medical devices and equipment industry looks buoyant, given rising chronic conditions and the adoption of advanced technology. Given this backdrop, would it be prudent for investors to buy medical stocks, Terumo Corporation (TRUMY), Haemonetics Corp. (HAE), and MiMedx Group (MDXG)? Read more to find out….

inkl

Read news from The Economist, FT, and more,
with one subscription

MDXG: 2Q:22 Financial and Operational Results

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT

5 Top-Rated Stocks Under $5 to Buy This Month

5 Top-Rated Stocks Under $5 to Buy This Month

Surging inflation and the probability the Federal Reserve will tighten its monetary policy further have driven a massive market sell-off lately. Amid ongoing geopolitical tensions and intensifying supply chain disruptions, investors fear that rising interest rates could push the economy into a recession. Therefore, we think it could be wise…

MiMedx Group's Return on Invested Capital Insights

MiMedx Group's Return on Invested Capital Insights

Benzinga Pro data, MiMedx Group (NASDAQ:MDXG) reported Q1 sales of $58.89 million. Earnings fell to a loss of $10.49 million, resulting in a 573.54% decrease from last quarter.

MDXG: 1Q:22 Financial and Operational Results

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT

Recap: MiMedx Group Q1 Earnings

Recap: MiMedx Group Q1 Earnings

MiMedx Group (NASDAQ:MDXG) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MiMedx Group missed estimated earnings by 10.0%, reporting an EPS of $-0.11 versus an estimate of $-0.1.

Earnings Outlook For MiMedx Group

Earnings Outlook For MiMedx Group

MiMedx Group (NASDAQ:MDXG) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that MiMedx Group will report an earnings per share (EPS) of $-0.10.

3 Biotech Stocks Under $5 to Buy Now

3 Biotech Stocks Under $5 to Buy Now

Rising cases of chronic diseases and growing investments in research and development to find better cures for a wealth of maladies are expected to bolster the biotech industry’s growth. An aging population should also boost the demand for biotech products. Therefore, we think it could be wise to invest now…

Get all your
news in one place.

100’s of premium titles.
One news app.

Looking Into MiMedx Group's Return On Invested Capital

According to Benzinga Pro, during Q4, MiMedx Group (NASDAQ:MDXG) earned $2.21 million, a 194.7% increase from the preceding quarter. MiMedx Group also posted a total of $67.41 million in sales, a 6.87% increase since Q3.

People

Kritika SarmahHer

Steve Reitmeister

Sristi Suman JayaswalThe

John Vandermosten

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Department of Defense

CVS Health Corporation

Cardinal Health Inc

Agilent Technologies

Elevance Health Inc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Economic Growth

Places

252,710 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play